Duker Jay S.

EyePoint Pharmaceuticals, Inc. · President and CEO

Duker Jay S. is listed in public filings as director, officer: President and CEO. This Duker Jay S. insider trading page organizes Form 4 disclosures, reported purchases and sales, transaction dates, share amounts, related issuers, and historical insider activity so readers can review the person's public trading record in one place. Companies and tickers connected to this insider trading profile include EyePoint Pharmaceuticals, Inc. (EYPT). Investors use Duker Jay S.'s insider trading disclosures to study buying and selling patterns, position changes, company-specific activity, and the source evidence behind each reported transaction.

Latest Actions

Company	Holding Value	Last Transaction	Amount	Transaction Price	Current Price
EyePoint Pharmaceuticals, Inc.EYPT	$1.7M82.5k shares	OtherMar 23, 2026	$2.0M97.5k shares	$20.40	--
EyePoint Pharmaceuticals, Inc.EYPT	$13k986 shares	OtherMar 23, 2026	$1.0M76.8k shares	$13.11	--
EyePoint Pharmaceuticals, Inc.EYPT	$102k7.8k shares	OtherMar 23, 2026	$689.3K52.5k shares	$13.13	--

Insider Trades History

Company	Holding Value	Last Transaction	Amount	Transaction Price	Current Price
EyePoint Pharmaceuticals, Inc.EYPT	$1.3M100.7k shares	BuyMar 16, 2026	$19.7K1.5k shares	$13.15	--
EyePoint Pharmaceuticals, Inc.EYPT	--20.8k shares	Grant / ExerciseJan 6, 2026	Disclosure amount unavailable20.8k shares	--	--
EyePoint Pharmaceuticals, Inc.EYPT	$1.3M77.8k shares	Grant / ExerciseJan 6, 2026	$169.5K10.1k shares	$16.86	--
EyePoint Pharmaceuticals, Inc.EYPT	$1.2M67k shares	Grant / ExerciseJan 5, 2026	$252.8K14.5k shares	$17.43	--
EyePoint Pharmaceuticals, Inc.EYPT	--30k shares	Grant / ExerciseJan 5, 2026	Disclosure amount unavailable30k shares	--	--
EyePoint Pharmaceuticals, Inc.EYPT	$901k51.5k shares	Grant / ExerciseJan 3, 2026	$409.9K23.4k shares	$17.48	--
EyePoint Pharmaceuticals, Inc.EYPT	--75k shares	Grant / ExerciseJan 3, 2026	Disclosure amount unavailable65k shares	--	--
EyePoint Pharmaceuticals, Inc.EYPT	$5.8M331k shares	Grant / ExerciseJan 2, 2026	$5.8M331k shares	$17.48	--
EyePoint Pharmaceuticals, Inc.EYPT	--165k shares	Grant / ExerciseJan 2, 2026	Disclosure amount unavailable165k shares	--	--
EyePoint Pharmaceuticals, Inc.EYPT	--16.7k shares	Grant / ExerciseJul 10, 2025	Disclosure amount unavailable16.7k shares	--	--
EyePoint Pharmaceuticals, Inc.EYPT	$110k10k shares	Grant / ExerciseJul 10, 2025	$85.0K7.7k shares	$11.06	--
EyePoint Pharmaceuticals, Inc.EYPT	$8.1k986 shares	OtherJun 23, 2025	$465.2K56.7k shares	$8.21	--
EyePoint Pharmaceuticals, Inc.EYPT	$355k57.7k shares	OtherMar 19, 2025	$123.1K20k shares	$6.16	--
EyePoint Pharmaceuticals, Inc.EYPT	--7k shares	Grant / ExerciseFeb 9, 2025	Disclosure amount unavailable7k shares	--	--
EyePoint Pharmaceuticals, Inc.EYPT	$504k77.7k shares	Grant / ExerciseFeb 9, 2025	$13.3K2.1k shares	$6.50	--
EyePoint Pharmaceuticals, Inc.EYPT	--39.2k shares	Grant / ExerciseJan 6, 2025	Disclosure amount unavailable20.8k shares	--	--
EyePoint Pharmaceuticals, Inc.EYPT	$631k72.7k shares	Grant / ExerciseJan 6, 2025	$53.0K6.1k shares	$8.68	--
EyePoint Pharmaceuticals, Inc.EYPT	--60k shares	Grant / ExerciseJan 5, 2025	Disclosure amount unavailable30k shares	--	--
EyePoint Pharmaceuticals, Inc.EYPT	$479k58k shares	Grant / ExerciseJan 5, 2025	$82.7K10k shares	$8.26	--
EyePoint Pharmaceuticals, Inc.EYPT	$3.2M390k shares	Grant / ExerciseJan 3, 2025	$3.2M390k shares	$8.26	--
EyePoint Pharmaceuticals, Inc.EYPT	--228.3k shares	Grant / ExerciseJan 3, 2025	Disclosure amount unavailable195k shares	--	--
EyePoint Pharmaceuticals, Inc.EYPT	--33.3k shares	Grant / ExerciseJul 10, 2024	Disclosure amount unavailable16.7k shares	--	--
EyePoint Pharmaceuticals, Inc.EYPT	$330k38k shares	Grant / ExerciseJul 10, 2024	$70.0K8.1k shares	$8.69	--